(Q45126334)

9 December 2017

Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours (English)

1 reference

9 December 2017

1

1 reference

9 December 2017

Davide Campana

4

0 references

author name string

Paola Tomassetti

2

1 reference

9 December 2017

Paolo Castellucci

3

1 reference

9 December 2017

Giancarlo Montini

5

1 reference

9 December 2017

Domenico Rubello

6

1 reference

9 December 2017

Cristina Nanni

7

1 reference

9 December 2017

Anna Rizzello

8

1 reference

9 December 2017

Roberto Franchi

9

1 reference

9 December 2017

Stefano Fanti

10

1 reference

9 December 2017

17 April 2008

1 reference

9 December 2017

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

9 December 2017

35

1 reference

9 December 2017

8

1 reference

9 December 2017

1431-1438

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-008-0769-2

9 December 2017

0 references

cites work

Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-008-0769-2

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-008-0769-2

Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

21 January 2018

1 reference

12 December 2020

Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors

1 reference

12 December 2020

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours.

1 reference

12 December 2020

Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?

1 reference

12 December 2020

Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study

1 reference

12 December 2020

Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis

1 reference

12 December 2020

Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid

1 reference

12 December 2020

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

1 reference

12 December 2020

Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors

1 reference

12 December 2020

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

1 reference

12 December 2020

Neuroendocrine tumour of the mediastinum: fusion of 18F-FDG and 68Ga-DOTATOC PET/CT datasets demonstrates different degrees of differentiation.

1 reference

12 December 2020

Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland

1 reference

12 December 2020

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours

1 reference

12 December 2020

Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC.

1 reference

12 December 2020

Somatostatin receptors and somatostatin content in medullary thyroid carcinomas

1 reference

12 December 2020

Current status of gastrointestinal carcinoids

1 reference

12 December 2020

Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma

1 reference

12 December 2020

Epidemiology of neuroendocrine tumours

1 reference

12 December 2020

Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.

1 reference

12 December 2020

Incidence and management of malignant digestive endocrine tumours in a well defined French population

1 reference

12 December 2020

A 5-decade analysis of 13,715 carcinoid tumors

1 reference

12 December 2020

Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography

1 reference

12 December 2020

68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors

1 reference

12 December 2020

68Ga-labelled DOTA-derivatised peptide ligands

1 reference

12 December 2020

68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5.

1 reference

12 December 2020

Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy

1 reference

12 December 2020

Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.

1 reference

12 December 2020

Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.

1 reference

12 December 2020

Nuclear imaging of neuroendocrine tumours

1 reference

12 December 2020

Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS.

1 reference

12 December 2020

Tumour biology and histopathology of neuroendocrine tumours

1 reference

12 December 2020

10.1007/S00259-008-0769-2

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference